位置:首页 > 蛋白库 > CTIP_MOUSE
CTIP_MOUSE
ID   CTIP_MOUSE              Reviewed;         893 AA.
AC   Q80YR6;
DT   16-MAY-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   03-AUG-2022, entry version 145.
DE   RecName: Full=DNA endonuclease RBBP8;
DE            EC=3.1.-.-;
DE   AltName: Full=CtBP-interacting protein;
DE            Short=CtIP;
DE   AltName: Full=Retinoblastoma-binding protein 8;
DE            Short=RBBP-8;
DE   AltName: Full=Retinoblastoma-interacting protein and myosin-like;
DE            Short=RIM;
DE   AltName: Full=Sporulation in the absence of SPO11 protein 2 homolog;
DE            Short=SAE2;
GN   Name=Rbbp8; Synonyms=Ctip;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Limb;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233 AND SER-720, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [4]
RP   RETRACTED PAPER.
RX   PubMed=20829486; DOI=10.1126/science.1192049;
RA   Kaidi A., Weinert B.T., Choudhary C., Jackson S.P.;
RT   "Human SIRT6 promotes DNA end resection through CtIP deacetylation.";
RL   Science 329:1348-1353(2010).
RN   [5]
RP   RETRACTION NOTICE OF PUBMED:20829486.
RX   PubMed=30975768; DOI=10.1126/science.aax4558;
RA   Kaidi A., Weinert B.T., Choudhary C., Jackson S.P.;
RL   Science 364:247-247(2019).
RN   [6]
RP   FUNCTION.
RX   PubMed=21131978; DOI=10.1038/nsmb.1940;
RA   Zhang Y., Jasin M.;
RT   "An essential role for CtIP in chromosomal translocation formation through
RT   an alternative end-joining pathway.";
RL   Nat. Struct. Mol. Biol. 18:80-84(2011).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DNA-BINDING.
RX   PubMed=21131982; DOI=10.1038/nsmb.1942;
RA   Lee-Theilen M., Matthews A.J., Kelly D., Zheng S., Chaudhuri J.;
RT   "CtIP promotes microhomology-mediated alternative end joining during class-
RT   switch recombination.";
RL   Nat. Struct. Mol. Biol. 18:75-79(2011).
CC   -!- FUNCTION: Endonuclease that cooperates with the MRE11-RAD50-NBN (MRN)
CC       complex in DNA-end resection, the first step of double-strand break
CC       (DSB) repair through the homologous recombination (HR) pathway (By
CC       similarity). HR is restricted to S and G2 phases of the cell cycle and
CC       preferentially repairs DSBs resulting from replication fork collapse
CC       (By similarity). Key determinant of DSB repair pathway choice, as it
CC       commits cells to HR by preventing classical non-homologous end-joining
CC       (NHEJ) (By similarity). Functions downstream of the MRN complex and
CC       ATM, promotes ATR activation and its recruitment to DSBs in the S/G2
CC       phase facilitating the generation of ssDNA (By similarity). Component
CC       of the BRCA1-RBBP8 complex that regulates CHEK1 activation and controls
CC       cell cycle G2/M checkpoints on DNA damage (By similarity). During
CC       immunoglobulin heavy chain class-switch recombination, promotes
CC       microhomology-mediated alternative end joining (A-NHEJ) and plays an
CC       essential role in chromosomal translocations (PubMed:21131978,
CC       PubMed:21131982). {ECO:0000250|UniProtKB:Q99708,
CC       ECO:0000269|PubMed:21131978, ECO:0000269|PubMed:21131982}.
CC   -!- SUBUNIT: Homodimer; dimerizes via the coiled coil domain. Interacts
CC       (via the PXDLS motif) with CTBP1; the interaction is disrupted via
CC       binding of the adenovirus E1A to CTBP1. Component of the BRCA1-RBBP8
CC       complex. Interacts (the Ser-326 phosphorylated form) with BRCA1 (via
CC       the C-terminal BRCA1 domains): the interaction occurs in the G2 phase,
CC       ubiquitinates RBBP8 and involves RBBP8 in BRCA1-dependent G2/M
CC       checkpoint control on DNA damage. Interacts with RB1. Interacts with
CC       the MRN complex. Interacts directly with MRE11; the interaction is
CC       required for efficient homologous recombination (HR) and regulation of
CC       the MRN complex. Interacts directly with RAD50. Interacts directly with
CC       NBN. Interacts with LM04 (via the LIM zinc-binding 1 domain). Interacts
CC       with SIAH1. Interacts with RNF138. Interacts with EXD2. Interacts with
CC       CUL3 and KLHL15; this interaction leads to RBBP8 proteasomal
CC       degradation. Directly interacts with PIN1; this interaction depends
CC       upon RBBP8 phosphorylation, predominantly at Thr-315. Interacts with
CC       FZR1; this interaction leads to APC/C-mediated RBBP8 proteasomal
CC       degradation. Interacts with AUNIP; leading to recruit RBBP8 to sites of
CC       DNA damage. Interacts with SAMHD1 (By similarity). Interacts with
CC       HDGFL2 (By similarity). {ECO:0000250|UniProtKB:Q99708}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q99708}.
CC       Chromosome {ECO:0000250|UniProtKB:Q99708}. Note=Associates with sites
CC       of DNA damage in S/G2 phase. Ubiquitinated RBBP8 binds to chromatin
CC       following DNA damage. {ECO:0000250|UniProtKB:Q99708}.
CC   -!- DOMAIN: The damage-recruitment motif is required for DNA binding and
CC       translocation to sites of DNA damage. {ECO:0000250}.
CC   -!- DOMAIN: The PXDLS motif binds to a cleft in CtBP proteins.
CC       {ECO:0000250|UniProtKB:Q99708}.
CC   -!- PTM: Hyperphosphorylation upon ionizing radiation results in
CC       dissociation from BRCA1. Phosphorylation at Thr-843 by CDK1 is
CC       essential for the recruitment to DNA and the DNA repair function.
CC       Phosphorylated at Ser-326 as cells enter G2 phase. This phosphorylation
CC       is required for binding BRCA1 and for the G2/M DNA damage transition
CC       checkpoint control (By similarity). Phosphorylation at Thr-315 is
CC       required for PIN1-binding, while phosphorylation at Ser-276 serves as a
CC       PIN1 isomerization site. Phosphorylation at Thr-315 is cell-cycle
CC       dependent. It steadily increases during S phase, peaks at late S/G2
CC       phase, and drops at G1 (By similarity). {ECO:0000250|UniProtKB:Q99708}.
CC   -!- PTM: Ubiquitinated. Ubiquitination at multiple sites by BRCA1 (via its
CC       N-terminal RING domain) does not lead to its proteasomal degradation
CC       but instead the ubiquitinated RBBP8 binds to chromatin following DNA
CC       damage and may play a role in G2/M checkpoint control. Ubiquitinated by
CC       RNF138 at its N-terminus. Ubiquitinated through 'Lys-48' by the E3
CC       CUL3-KLHL15 complex; this modification leads to proteasomal
CC       degradation. Ubiquitinated by the E3 FZR1/APC/C complex; this
CC       modification leads to proteasomal degradation.
CC       {ECO:0000250|UniProtKB:Q99708}.
CC   -!- SIMILARITY: Belongs to the COM1/SAE2/CtIP family. {ECO:0000305}.
CC   -!- CAUTION: Upon DNA damage, was shown to interact with SIRT6 resulting in
CC       its deacetylation. However, this study was later retracted.
CC       {ECO:0000305|PubMed:20829486, ECO:0000305|PubMed:30975768}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC090479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115894; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050849; AAH50849.1; -; mRNA.
DR   CCDS; CCDS37738.1; -.
DR   RefSeq; NP_001074692.1; NM_001081223.2.
DR   RefSeq; NP_001239424.1; NM_001252495.1.
DR   RefSeq; XP_006525875.1; XM_006525812.3.
DR   AlphaFoldDB; Q80YR6; -.
DR   SMR; Q80YR6; -.
DR   BioGRID; 230366; 6.
DR   ComplexPortal; CPX-4722; BRCA1-C complex.
DR   IntAct; Q80YR6; 1.
DR   STRING; 10090.ENSMUSP00000046255; -.
DR   iPTMnet; Q80YR6; -.
DR   PhosphoSitePlus; Q80YR6; -.
DR   EPD; Q80YR6; -.
DR   jPOST; Q80YR6; -.
DR   PaxDb; Q80YR6; -.
DR   PRIDE; Q80YR6; -.
DR   ProteomicsDB; 283978; -.
DR   Antibodypedia; 7316; 460 antibodies from 42 providers.
DR   DNASU; 225182; -.
DR   Ensembl; ENSMUST00000047322; ENSMUSP00000046255; ENSMUSG00000041238.
DR   Ensembl; ENSMUST00000115861; ENSMUSP00000111527; ENSMUSG00000041238.
DR   GeneID; 225182; -.
DR   KEGG; mmu:225182; -.
DR   UCSC; uc008ebl.1; mouse.
DR   CTD; 5932; -.
DR   MGI; MGI:2442995; Rbbp8.
DR   VEuPathDB; HostDB:ENSMUSG00000041238; -.
DR   eggNOG; ENOG502QTV5; Eukaryota.
DR   GeneTree; ENSGT00530000063835; -.
DR   HOGENOM; CLU_019262_0_0_1; -.
DR   InParanoid; Q80YR6; -.
DR   OMA; FKIPLCP; -.
DR   OrthoDB; 962036at2759; -.
DR   PhylomeDB; Q80YR6; -.
DR   TreeFam; TF106469; -.
DR   Reactome; R-MMU-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-MMU-5685939; HDR through MMEJ (alt-NHEJ).
DR   Reactome; R-MMU-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-MMU-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-MMU-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-MMU-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-MMU-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-MMU-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-MMU-69473; G2/M DNA damage checkpoint.
DR   BioGRID-ORCS; 225182; 18 hits in 110 CRISPR screens.
DR   ChiTaRS; Rbbp8; mouse.
DR   PRO; PR:Q80YR6; -.
DR   Proteomes; UP000000589; Chromosome 18.
DR   RNAct; Q80YR6; protein.
DR   Bgee; ENSMUSG00000041238; Expressed in undifferentiated genital tubercle and 221 other tissues.
DR   ExpressionAtlas; Q80YR6; baseline and differential.
DR   Genevisible; Q80YR6; MM.
DR   GO; GO:0070533; C:BRCA1-C complex; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IC:ComplexPortal.
DR   GO; GO:0035861; C:site of double-strand break; IBA:GO_Central.
DR   GO; GO:0017053; C:transcription repressor complex; ISO:MGI.
DR   GO; GO:0003684; F:damaged DNA binding; ISO:MGI.
DR   GO; GO:0000406; F:double-strand/single-strand DNA junction binding; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0070336; F:flap-structured DNA binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:MGI.
DR   GO; GO:0003697; F:single-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0000014; F:single-stranded DNA endodeoxyribonuclease activity; ISO:MGI.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:MGI.
DR   GO; GO:0000403; F:Y-form DNA binding; IBA:GO_Central.
DR   GO; GO:0001835; P:blastocyst hatching; IMP:MGI.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0010792; P:DNA double-strand break processing involved in repair via single-strand annealing; ISO:MGI.
DR   GO; GO:0110025; P:DNA strand resection involved in replication fork processing; IC:ComplexPortal.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IBA:GO_Central.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:MGI.
DR   GO; GO:0035825; P:homologous recombination; IC:ComplexPortal.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0044818; P:mitotic G2/M transition checkpoint; IC:ComplexPortal.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; ISS:UniProtKB.
DR   InterPro; IPR019518; CtIP_N.
DR   InterPro; IPR013882; Ctp1_C.
DR   InterPro; IPR033594; RBBP8.
DR   InterPro; IPR033316; RBBP8-like.
DR   PANTHER; PTHR15107; PTHR15107; 1.
DR   PANTHER; PTHR15107:SF4; PTHR15107:SF4; 1.
DR   Pfam; PF10482; CtIP_N; 1.
DR   Pfam; PF08573; SAE2; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Chromosome; Coiled coil; DNA damage; DNA repair;
KW   DNA-binding; Endonuclease; Hydrolase; Isopeptide bond; Meiosis; Mitosis;
KW   Nuclease; Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..893
FT                   /note="DNA endonuclease RBBP8"
FT                   /id="PRO_0000417036"
FT   REGION          22..45
FT                   /note="Essential for binding to the MRN complex and for RPA
FT                   focus formation on DNA damage"
FT                   /evidence="ECO:0000250"
FT   REGION          296..324
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          489..493
FT                   /note="PXDLS motif"
FT   REGION          508..556
FT                   /note="Damage-recruitment motif"
FT                   /evidence="ECO:0000250"
FT   REGION          869..893
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          54..149
FT                   /evidence="ECO:0000255"
FT   MOTIF           836..838
FT                   /note="KLHL15-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   COMPBIAS        310..324
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         276
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         315
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         378
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         662
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         677
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         720
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         742
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   MOD_RES         843
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        62
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        115
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        193
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        359
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        377
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        394
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        403
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        409
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        437
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        525
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        529
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        570
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        576
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        602
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        611
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        636
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        638
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        674
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        716
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        778
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
FT   CROSSLNK        865
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99708"
SQ   SEQUENCE   893 AA;  100831 MW;  2F363F88D2190F13 CRC64;
     MSISGSGCGS PNSADASNDF KELWTKLKEY HDKEVQGLQV KVTKLKKERI LDAQRLEEFF
     TKNQQLRDQQ KVLQETIKIL EDRLRAGLCD RCAVTEEHMH KKQQEFENIR QQNLKLITEL
     MNEKNTLQEE NKKLSEQLQQ KMENGQQDQV AELACEENII PDSPVTSFSF SGINRLRKKE
     NLHVRYVEQT HTKLERSLCT NELRKISKDS APAPVNSEEH EILVADTCDQ NHSPLSKICE
     TSSYPTDKTS FNLDTVVAET LGLNGQEESE PQGPMSPLGS ELYHCLKEDH KKHPFMESAR
     SKEDSLRFSD SASKTPPQEF TTRASSPVFG ATSTVKAHLG LNTSFSPSLL DIGKKNLLKT
     APFSNIAVSR SEKVRSKSED NALFTQHSLG SEVKVISQSF SSKQILTNKT VSDSVDEQCS
     ADHMNTTVAD KYLVPLKSLG GKASKRKRTE EESEHAVKCP QACFDKENAL PFPMENQFSM
     NGDHVMDKPL DLSDRFAATQ RQEKNHGNET SKNKLKQATI YEALKPIPKG SSSGRKALSG
     DCMPAKDSWE TYCLQPRSLQ SSSKFSPDQK TPLQIKEENP VFKTPPCSQE SLETENLFGD
     VKGTGSLVPT KVKSRAVHGG CELASVLQLN PCRVAKTKAL PSNQDTSFEN IQWSVDPGAD
     LSQYKMDVTV IDTKDSSHSR LGGETVDMDC TLVSETVLLK MKKQEQKERS PNGDIKMNDS
     LEDMFDRTTH EEYESCLADS FSQVPDEEEL PDTTKKTNIP ADKQDGVKQK AFVGPYFKDK
     ERETSIQNFP HIEVVRKKEE RRKLLGHTCK ECEIYYADLP AEEREKKLAS CSRHRFRYIP
     PNTPENFWEV GFPSTQTCLE RGYIKEDLDL SPRPKRRQPY NAVFSPKGKE QRT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024